Dr. Vinnard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1427 Vine St
2nd Floor
Philadelphia, PA 19102Phone+1 215-762-2533Fax+1 215-762-2531
Education & Training
- University of Pennsylvania Health SystemFellowship, Infectious Disease, 2009 - 2011
- NYU Grossman School of MedicineResidency, Internal Medicine, 2002 - 2005
- Tulane University School of MedicineClass of 2002
Certifications & Licensure
- NJ State Medical License 2016 - 2025
- PA State Medical License 2007 - 2016
- HI State Medical License Active through 2014
- NY State Medical License 2004 - 2007
- AL State Medical License 2005 - 2005
Clinical Trials
- Immune Activation and Drug Absorption in HIV-Infected Patients Start of enrollment: 2014 Jun 01
Publications & Presentations
PubMed
- 14 citationsDetermination of Rifampin Concentrations by Urine Colorimetry and Mobile Phone Readout for Personalized Dosing in Tuberculosis Treatment.Claire Szipszky, Daniel Van Aartsen, Sarah Criddle, Prakruti Rao, Isaac Zentner
Journal of the Pediatric Infectious Diseases Society. 2021-03-26 - 9 citationsGuidelines-based treatment associated with improved economic outcomes in nontuberculous mycobacterial lung diseaseTheodore K. Marras, Mehdi Mirsaeidi, Christopher Vinnard, Edward D. Chan, Gina Eagle
Journal of Medical Economics. 2019-06-10 - 36 citationsRelative risk of all-cause mortality in patients with nontuberculous mycobacterial lung disease in a US managed care population.Theodore K. Marras, Christopher Vinnard, Quanwu Zhang, Keith W. Hamilton, Jennifer Adjemian
Respiratory Medicine. 2018-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: